Skip to main content
. 2020 Apr 19;108(2):316–325. doi: 10.1002/cpt.1831

Table 1.

Patient demographics and characteristics

Characteristic Study 1 (n = 66) Study 2 (n = 33) Study 3 (n = 50) Pediatric IIR (n = 14) Total (N = 163)
Number of PK samples 281 123 283 110 797
Male, n (%) 36 (54.55) 20 (60.61) 30 (60) 9 (64.29) 95 (58.28)
Race, n (%)
White 52 (78.79) 26 (78.79) 48 (96) 10 (71.43) 136 (83.44)
Black 1 (1.52) 4 (12.12) 1 (2) 4 (28.57) 10 (6.13)
Asian 6 (9.09) 2 (6.06) 0 (0) 0 (0) 8 (4.91)
Other 7 (10.61) 1 (3.03) 0 (0) 0 (0) 8 (4.91)
Missing 0 (0) 0 (0) 1 (2) 0 (0) 0 (0)
Age, years
Mean (SD) 5.9 (5.14) 53.2 (18.83) 58.2 (13.74) 82.1 (124.10) a 31.0 (28.38)
Median (range) 4 (0.10–17) 59 (20–81) 58.5 (25–80) 26.3 (1.8–451.1) a 21 (1.8 a –81)
Body weight, kg
Mean (SD) 23.0 (19.09) 77.8 (19.37) 73.8 (27.31) 3.2 (2.61) 48.0 (35.51)
Median (range) 16.6 (2.31–85.7) 77.2 (37.8–122.1) 70.0 (48.0–240.0) 2.8 (0.75–9.47) 54.0 (0.75–240.0)

PK, pharmacokinetics; SD, standard deviation.

a

Age, days.